Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive vs. Emotional Pharmacological Manipulations of Fear and Anxiety
NCT02153944Phase 4Completed
- Sponsor
- National Institute of Mental Health
- Start
- Jun 2014
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in anxiety disorders, sponsored by National Institute of Mental Health. Started Jun 2014; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
anxiety disorders
Beyond the preview
Go deeper on NCT02153944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153944.